Nyxoah S.A. - צמיחת מכירות משנה לשנה (TTM) NYXH

Flawless air delivery ensures that clinics receive critical Nyxoah S.A. (NYXH) implants on time. The relative change in rolling year revenue compared to the same period last year demonstrates revenue dynamics, where the value of 433.30 expresses the metric level. Nyxoah S.A. develops neurostimulators for apnea therapy, expanding its reach within the sleep medicine market. The business is currently focused on FDA approval and the development of US B2B distribution channels.
Nyxoah S.A. - פילוחים אנליטיים ומדדי מפתח (NYXH)

Nyxoah S.A. is currently scaling the commercial rollout of its apnea treatment systems while facing high costs associated with expanding its sales force. TTM revenue dynamics measure the growth rate of inflows, allowing for an assessment of the company's pricing power to pass inflation onto customers and real demand, which is clearly reflected in the annual sales trend over four quarters, warning of the risks associated with a low base effect.